SCHEMBL22949362

SCHEMBL22949362

C[Si]1(C)c2ccccc2-c2cc(-c3cccc(-c4cccc(-c5ccc(-c6cc(-c7cccc(-c8ccccc8)c7)nc(-c7ccccc7)n6)cc5)c4)c3)ccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.46
KMT2A Q03164 10/20 0.46
MAPT P10636 8/20 0.46
ALDH1A1 P00352 7/20 0.46
HPGD P15428 7/20 0.46
KDM4E B2RXH2 5/20 0.46
LMNA P02545 2/20 0.46
GLA P06280 1/20 0.46
NTSR1 P30989 1/20 0.44
NPSR1 Q6W5P4 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
CYP2C19 P33261 1/20 0.40
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
MAOB P27338 5/20 0.38
MAOA P21397 3/20 0.38
RORA P35398 1/20 0.37
RORC P51449 1/20 0.37
TDP1 Q9NUW8 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22949607 0.99 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22947245 0.99 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22947379 0.96 MEN1 (0.43) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22947425 0.96 MEN1 (0.47) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22949363 0.96 MEN1 (0.47) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22947424 0.96 MEN1 (0.47) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22949595 0.95 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22948129 0.92 MEN1 (0.46) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22947417 0.92 RORA (0.40) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22947587 0.92 RORA (0.40) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 MEN1 2439/4885KMT2A 2115/4885MAPT 3103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.